Tag: Pharmaceutical
Industrial cybersecurity startup Claroty raises $140M in pre-IPO funding round
Claroty, an industrial cybersecurity company that helps customers protect and manage their Internet of Things (IoT) and operational technology (OT) assets, has raised $140 million in its latest, and potentially last round of funding. With the new round of Series D funding, co-led by Bessemer Venture and 40 North, the…
Read More
Ada Health closes $90M Series B led by Leaps by Bayer
The digital health space continues cooking on gas: Berlin-based Ada Health has closed a $90M Series B round of funding led by Leaps by Bayer, the impact investment arm of the German multinational pharma giant, Bayer AG. Other investors in the round include Samsung Catalyst Fund, Vitruvian Partners, Inteligo Bank,…
Read More
K Health expands into virtual childcare and raises $132 million at a $1.5 billion valuation
K Health, the virtual health care provider that uses machine learning to lower the cost of care by providing the bulk of the company’s health assessments, is launching new tools for childcare on the heels of raising cash that values the company at $1.5 billion. The $132 million round raised…
Read More
AstraZeneca says it will likely do another study of COVID-19 vaccine after accidental lower dose shows higher efficacy
AstraZeneca’s CEO told Bloomberg that the pharmaceutical company will likely conduct another global trial of the effectiveness of its COVID-19 vaccine trial, following the disclosure that the more effective dosage in the existing Phase 3 clinical trial was actually administered by accident. AstraZeneca and its partner the University of Oxford…
Read More
Emerging from stealth, Octant is bringing the tools of synthetic biology to large scale drug discovery
Octant, a company backed by Andreessen Horowitz just now unveiling itself publicly to the world, is using the tools of synthetic biology to buck the latest trends in drug discovery. As the pharmaceuticals industry turns its attention to precision medicine — the search for ever more tailored treatments for specific…
Read More
Owkin raises $25 million as it builds a secure network for healthcare analysis and research
Imagine a model of collaborative research and development among hospitals, pharmaceutical companies, universities and other research institutions where no one shared any actual data. That’s the dream of the new New York-based startup Owkin, which has raised $25 million in fresh financing from investors including Bpifrance Large Venture, Cathay Innovation and…
Read More